Description
CJC-1295 and Ipamorelin are research peptides commonly studied in relation to growth hormone (GH) signaling pathways and their role in physiological regulation.
CJC-1295 is a growth hormone releasing hormone (GHRH) analog, while Ipamorelin is a selective ghrelin receptor agonist. Together, they are frequently investigated for their combined effects on growth hormone release patterns and downstream signaling pathways.
⸻
Areas of Research Interest:
• Growth hormone secretion and pulsatility
• IGF-1 signaling pathways
• tissue repair mechanisms
• Sleep-related hormonal regulation
⸻
Frequently Explored in Research Alongside:
IGF-1 LR3
• Investigated for its role in IGF-1 signaling and cellular growth pathways
• Often studied in conjunction with GH-related compounds
Tesamorelin
• GHRH analog studied for targeted GH pathway stimulation
• May be explored in comparative or complementary GH research
BPC-157 / TB-500
• Studied for tissue repair and cellular repair pathways
• Often explored in research involving cellular repair and healing mechanisms
⸻
Product Details:
• 5mg CJC-1295 / 5mg Ipamorelin blend
• Lyophilized powder
• High purity (third-party tested)
• Research-grade quality
⸻
Storage:
Store refrigerated after reconstitution
Keep in a cool, dry environment prior to reconstitution
⸻
Disclaimer:
This product is intended strictly for laboratory and research use only.
Not for human consumption.
Not intended to diagnose, treat, cure, or prevent any disease.
